Tirzepatide Tirzepatide GLP-1 is a dual-action metabolic therapy that supports weight control by improving insulin sensitivity, reducing appetite, and enhancing satiety
MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis
An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success
The concern is theoretical and would apply equally to combining dulaglutide with other antioxidants like N-acetylcysteine or vitamin C
Transactions 49, 10751083
Our results align with previous studies showing that caffeine increases BDNF expression in the hippocampus (Sallaberry et al